SINEFIX-2022 Fase Piloto
Investigación clínica previa a la comercialización Inovedis SINEFIX
Shoulder pain is one of the most commonly reported musculoskeletal complaints, which negatively affects upper limb use, night rest, daily life activities, work, sports performance and autonomy. Rotator cuff disease represents the most common cause of shoulder pain and it is responsible for up to 70% of all shoulder related visits to clinicians. Its incidence furthermore is expected to grow as the population ages. A wide range of conditions are included under the umbrella term of rotator cuff disease, including rotator cuff tendinopathy, subacromial bursal pathology, and partial-thickness or full-thickness rotator cuff tears (RCTs). The latter ones, i.e. rotator cuff tears, form the indications for which the test devices, the SINEFIX implant and instruments, are intended.
Despite the high prevalence of this condition, the pathophysiology and healing potential are not well understood, making the condition challenging to predictably treat in some patient populations. RCTs may occur in young people as a consequence of trauma (e.g. acute shoulder dislocation), however RCTs typically present in middle-aged or elderly people and cannot always be attributed to precipitating events or trauma. Instead, they can be attributed to degenerative processes, and are therefore referred to as degenerative RCTs.
For RCTs, treatment options include both surgical and non-surgical (conservative) procedures.
In this context, the SINEFIX implant and instruments were developed to treat adult patients with rotator cuff lesions of size up to 2 cm through arthroscopic reconstruction.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Tübingen, Alemania, 72074
- Orthopädisch Chirurgisches Centrum (OCC)
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Patient indicated for surgical repair of the rotator cuff tear according to current guidelines
- Patient aged 18 years or older
- Up to 2 cm tear size of supraspinatus, infraspinatus (medio-lateral)
- Up to 2 cm tear size of supraspinatus, infraspinatus (anterior-posterior)
Exclusion Criteria:
- Subject has had previous rotator cuff, arthroplasty or fracture procedures on the operative shoulder
- History of alcoholism, drug abuse, psychological or other emotional problems likely to interfere with participation in the study follow-up schedule and assessments
- Inflammatory arthropathies
- Subject with a contraindication/non-compliance for MRI examination
- Subject 's unwillingness to undergo surgical rotator cuff repair, participate in post-operative rehabilitation program, and / or adhere to follow up schedule
- Pregnant and breastfeeding woman
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: SINEFIX
Rotator cuff repair with the SINEFIX implant, using the SINEFIX instruments |
Treatment of rotator cuff lesions of size up to 2 cm using the SINEFIX implant and instruments |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Healing integrity
Periodo de tiempo: 3 months post operation
|
Healing integrity will be assessed with the MRI by evaluating the visibility of the tendon underneath the implant (yes/no) |
3 months post operation
|
|
Re-tear rate
Periodo de tiempo: 3 months post operation
|
Re-tear rate will be assessed with MRI |
3 months post operation
|
|
Dislocation of the implant
Periodo de tiempo: 3 months post operation
|
Presence of dislocation of the implant will be assessed with MRI (yes/no) |
3 months post operation
|
|
Bursitis
Periodo de tiempo: 3 months post operation
|
Presence of bursitis will be assessed with MRI (yes/no) |
3 months post operation
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Surgery time
Periodo de tiempo: Immediately post procedure
|
The total procedure duration will be recorded as the surgery time |
Immediately post procedure
|
|
Usability and workflow assessment
Periodo de tiempo: Immediately post procedure
|
Usability and workflow assessment will be evaluated after each intervention through a practitioner's questionnaire covering different aspects of the implant and instruments |
Immediately post procedure
|
|
Functional and clinical outcome after rotator cuff repair
Periodo de tiempo: At 6 months, 1 and 2 years follow-up
|
Functional and clinical outcome after rotator cuff repair will be assessed using the total Constant Murley score, which ranges from 0 (worst outcome) to 100 (best outcome) |
At 6 months, 1 and 2 years follow-up
|
|
Functional and clinical outcome after rotator cuff repair as compared with baseline
Periodo de tiempo: At 6 months, 1 and 2 years follow-up
|
Functional and clinical outcome after rotator cuff repair will be assessed using the change of the total Constant Murley score (range 0-100) as compared to baseline |
At 6 months, 1 and 2 years follow-up
|
|
Shoulder function after rotator cuff repair (subjective evaluation)
Periodo de tiempo: At 10 weeks, 6, 12, and 24 months
|
Shoulder function after rotator cuff repair (subjective evaluation) will be assessed through the Subjective Shoulder Value (SSV) which ranges from 0% to 100% (best outcome) |
At 10 weeks, 6, 12, and 24 months
|
|
Shoulder function after rotator cuff repair (physical examination-active external rotation)
Periodo de tiempo: At 10 weeks, 6, 12, and 24 months
|
Shoulder function after rotator cuff repair (physical examination) will be assessed through a physical examination with assessment of range of motion for active external rotation (range 0°-90°) |
At 10 weeks, 6, 12, and 24 months
|
|
Shoulder function after rotator cuff repair (physical examination-active anteversion)
Periodo de tiempo: At 10 weeks, 6, 12, and 24 months
|
Shoulder function after rotator cuff repair (physical examination) will be assessed through a physical examination with assessment of range of motion for active anteversion (0°-180°) |
At 10 weeks, 6, 12, and 24 months
|
|
Healing integrity
Periodo de tiempo: At 6, 12, and 24 months
|
Healing integrity will be assessed with the MRI by evaluating the visibility of the tendon underneath the implant (yes/no) |
At 6, 12, and 24 months
|
|
Re-tear rate
Periodo de tiempo: At 6, 12, and 24 months
|
Re-tear rate will be assessed with MRI |
At 6, 12, and 24 months
|
|
Dislocation of the implant
Periodo de tiempo: At 6, 12, and 24 months
|
Presence of dislocation will be assessed with MRI (yes/no) |
At 6, 12, and 24 months
|
|
Bursitis
Periodo de tiempo: At 6, 12, and 24 months
|
Presence of bursitis will be assessed with MRI (yes/no) |
At 6, 12, and 24 months
|
|
Complications
Periodo de tiempo: During the follow up time (up to 24 months)
|
Complications will be systematically reported. Complications of particular interest for the purpose of the study are neurological problems, bleeding, impaired wound healing, infection and frozen shoulder. |
During the follow up time (up to 24 months)
|
|
Patient satisfaction
Periodo de tiempo: At 10 weeks, 6, 12, 24 months
|
The patient will be asked to rate his/her satisfaction with outcome of the surgical repair (0=completely unsatisfied, 1=unsatisfied, 2=satisfied, 3=completely satisfied) |
At 10 weeks, 6, 12, 24 months
|
|
Safety endpoint
Periodo de tiempo: During the intervention and the follow up time (up to 24 months)
|
Safety of the device will be evaluated by systematically reporting device deficiencies (DDs), adverse events (AEs) and serious adverse events (SAEs) and by monitoring the frequency and incidence of these events |
During the intervention and the follow up time (up to 24 months)
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- SINEFIX-2022
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .